IL53171A - Substituted n-(carbamoylalkyl-carbamoylalkyl)-lactam derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

Substituted n-(carbamoylalkyl-carbamoylalkyl)-lactam derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL53171A
IL53171A IL53171A IL5317177A IL53171A IL 53171 A IL53171 A IL 53171A IL 53171 A IL53171 A IL 53171A IL 5317177 A IL5317177 A IL 5317177A IL 53171 A IL53171 A IL 53171A
Authority
IL
Israel
Prior art keywords
carbamoylalkyl
substituted
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL53171A
Other languages
English (en)
Other versions
IL53171A0 (en
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of IL53171A0 publication Critical patent/IL53171A0/xx
Publication of IL53171A publication Critical patent/IL53171A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08Oxygen atoms
    • C07D223/10Oxygen atoms attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cephalosporin Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL53171A 1976-10-22 1977-10-19 Substituted n-(carbamoylalkyl-carbamoylalkyl)-lactam derivatives,their preparation and pharmaceutical compositions containing them IL53171A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB43934/76A GB1539817A (en) 1976-10-22 1976-10-22 N-substituted lactams

Publications (2)

Publication Number Publication Date
IL53171A0 IL53171A0 (en) 1977-12-30
IL53171A true IL53171A (en) 1982-02-28

Family

ID=10431009

Family Applications (1)

Application Number Title Priority Date Filing Date
IL53171A IL53171A (en) 1976-10-22 1977-10-19 Substituted n-(carbamoylalkyl-carbamoylalkyl)-lactam derivatives,their preparation and pharmaceutical compositions containing them

Country Status (27)

Country Link
US (1) US4162325A (fr)
JP (1) JPS5839148B2 (fr)
AT (1) AT352742B (fr)
BE (1) BE859925A (fr)
BG (1) BG28413A3 (fr)
CA (1) CA1095040A (fr)
CH (1) CH625214A5 (fr)
CS (1) CS200231B2 (fr)
CY (1) CY1037A (fr)
DD (1) DD131930A5 (fr)
DE (1) DE2747369A1 (fr)
DK (1) DK461877A (fr)
ES (1) ES463424A1 (fr)
FI (1) FI66600C (fr)
FR (1) FR2368474B1 (fr)
GB (1) GB1539817A (fr)
HK (1) HK2380A (fr)
HU (1) HU174864B (fr)
IL (1) IL53171A (fr)
KE (1) KE3013A (fr)
MY (1) MY8000264A (fr)
NL (1) NL7711414A (fr)
PL (1) PL110679B1 (fr)
SE (1) SE425782B (fr)
SU (2) SU805945A3 (fr)
YU (1) YU251977A (fr)
ZA (1) ZA776260B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2960194D1 (en) * 1978-05-08 1981-04-16 Ucb Sa Lactam-n-acetic acids, their amides, process for their preparation and therapeutic compositions containing them
EP0115473A3 (fr) * 1983-01-27 1987-01-21 Ciba-Geigy Ag Dérivés substitués de pyrrolidinone et leur procédé de préparation
EP0115472A3 (fr) * 1983-01-27 1985-10-02 Ciba-Geigy Ag Dérivés de la pyrrolidinone et leur procédé de préparation
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
EP0419683A4 (en) * 1989-04-13 1992-03-11 Japan Tobacco Inc. New amino acid derivatives having prolylendopeptidase inhibitor activity
US5206386A (en) * 1991-03-20 1993-04-27 Isp Investments Inc. Controlled release N-substituted pyrrolidone esters and process for the use thereof
DE4308034A1 (de) * 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
US5658940A (en) * 1995-10-06 1997-08-19 Celgene Corporation Succinimide and maleimide cytokine inhibitors
US5914332A (en) * 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
CN114685342B (zh) * 2020-12-25 2024-05-10 长沙博源医疗科技有限公司 一种左乙拉西坦衍生物、免疫原、抗左乙拉西坦特异性抗体及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121723A (en) * 1955-11-02 1964-02-18 Sterling Drug Inc Lower alkyl n-(tertiary-amino-lower-alkyl) lower alkamates and quaternary ammonium salts thereof
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
NL7407140A (nl) * 1974-03-07 1975-09-09 Jose Maria Espinos Taya En Jos Werkwijze voor de bereiding van een n-gesub- stitueerd pyrrolidon.
AT360980B (de) * 1976-01-14 1981-02-10 Pliva Pharm & Chem Works Verfahren zur herstellung von n-alkylamiden des 2-oxo-1-pyrrolidins

Also Published As

Publication number Publication date
ZA776260B (en) 1978-07-26
GB1539817A (en) 1979-02-07
SU937450A1 (ru) 1982-06-23
DE2747369A1 (de) 1978-04-27
PL110679B1 (en) 1980-07-31
HU174864B (hu) 1980-03-28
FR2368474A1 (fr) 1978-05-19
BG28413A3 (en) 1980-04-15
IL53171A0 (en) 1977-12-30
US4162325A (en) 1979-07-24
FR2368474B1 (fr) 1980-08-08
YU251977A (en) 1983-01-21
DD131930A5 (de) 1978-08-09
AT352742B (de) 1979-10-10
JPS5353649A (en) 1978-05-16
PL201601A1 (pl) 1979-01-29
CY1037A (en) 1980-08-01
ES463424A1 (es) 1978-07-16
FI66600C (fi) 1984-11-12
CH625214A5 (fr) 1981-09-15
BE859925A (fr) 1978-04-20
DK461877A (da) 1978-04-23
ATA749677A (de) 1979-03-15
NL7711414A (nl) 1978-04-25
MY8000264A (en) 1980-12-31
DE2747369C2 (fr) 1987-11-12
JPS5839148B2 (ja) 1983-08-27
FI773069A (fi) 1978-04-23
FI66600B (fi) 1984-07-31
CS200231B2 (en) 1980-08-29
SU805945A3 (ru) 1981-02-15
HK2380A (en) 1980-01-25
CA1095040A (fr) 1981-02-03
SE425782B (sv) 1982-11-08
SE7711667L (sv) 1978-04-23
KE3013A (en) 1980-02-01

Similar Documents

Publication Publication Date Title
DE2862355D1 (en) Amine derivatives, their preparation and pharmaceutical compositions containing them
IL59524A0 (en) Indole derivatives,their preparation and pharmaceutical compositions containing them
IL53043A (en) N-heterocyclylalkyl-(1-aryloxy-2-hydroxy-3-amino-propane)derivatives,their preparation and pharmaceutical compositions containing them
NZ183150A (en) 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions
IL53094A0 (en) New hydantoin derivatives their preparation and pharmaceutical compositions containing them
IL52337A (en) Dipeptide derivatives,their manufacture and pharmaceutical compositions containing them
IL49325A (en) 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them
IL60087A0 (en) Sulphonamide derivatives,their preparation and pharmaceutical compositions containing them
IL49422A (en) Substitutet 1-(w-triarylalkyl)-4-phenyl-4-piperidine-methanol derivatives, their preparation and pharmaceutical compositions containing them
IL52307A (en) Dipeptide derivatives,their manufacture and pharmaceutical compositions containing them
IL52041A (en) Quinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL53171A (en) Substituted n-(carbamoylalkyl-carbamoylalkyl)-lactam derivatives,their preparation and pharmaceutical compositions containing them
IL51812A0 (en) New isothiazolopyridine derivatives their preparation and pharmaceutical compositions containing them
NZ184755A (en) 2-benzylpyrrolidine derivatives and pharmaceutical compositions
IL52717A (en) Derivatives of2-phenylamino-imidazoline-(2),their preparation and pharmaceutical compositions containing them
IL52857A (en) Oxo-benzopyrane derivatives,their preparation and pharmaceutical compositions containing them
NZ185642A (en) Morphanthridine derivatives and pharmaceutical compositions
NZ184102A (en) Derivatives of benzenesulphonylurea,and pharmaceutical compositions
NZ184103A (en) Fenzodioxole derivatives and pharmaceutical compositions
IL58648A0 (en) 7-chloro-3-alkoxycarbonyl-5-haolophenyl-2-oxo-2,3-dihydro-1,4-benzo-diazepine derivatives their preparation and pharmaceutical compositions containing them
IL53861A (en) N-substituted aralkylaniline derivatives,their preparation and pharmaceutical compositions containing them
IL51468A (en) 17 -hydroxy- -d-homosteroid derivatives,their preparation and pharmaceutical compositions containing them
NZ185267A (en) Derivatives of 1-amino-2hydroxy-3-heterocycloxy-propanes, and pharmaceutical compositions containing them
IL53642A0 (en) New indoloquinolizine derivatives their preparation and pharmaceutical compositions containing them
IL52006A0 (en) Novel nephthalene derivatives their preparation and pharmaceutical compositions containing them